scholarly journals Corrigendum to: “Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study”

Diabetologia ◽  
2018 ◽  
Vol 62 (1) ◽  
pp. 58-69 ◽  
Author(s):  
Ronald B. Goldberg ◽  
◽  
George A. Bray ◽  
Santica M. Marcovina ◽  
Kieren J. Mather ◽  
...  

BMC Nutrition ◽  
2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Benjamin T. Allaire ◽  
◽  
Ashley H. Tjaden ◽  
Elizabeth M. Venditti ◽  
John W. Apolzan ◽  
...  

Abstract Background We evaluated whether diet quality is a predictor of weight loss and reduced diabetes risk, independent of caloric intake in the Diabetes Prevention Program (DPP) cohort, a randomized clinical trial of adults at risk for diabetes. Methods This secondary analysis included 2914 participants with available data (964 intensive lifestyle (ILS), 977 metformin, 973 placebo). Dietary intake was assessed using a 117-item food frequency questionnaire. Diet quality was quantified using the Alternative Healthy Eating Index 2010 (AHEI). AHEI ranges from 0 to 110, with higher scores corresponding to higher quality diets. ILS participants had greater improvement (p < 0.001) in AHEI over 1-year (4.2 ± 9.0) compared to metformin (1.2 ± 8.5) and placebo (1.4 ± 8.4). We examined the association between AHEI change and weight change from baseline to 1-year using linear regression, and that between 1-year AHEI change and incident diabetes, using hazard models over an average 3 years follow-up. Models were evaluated within treatment group and adjusted for relevant characteristics including caloric intake, physical activity, BMI and AHEI. Models testing incident diabetes were further adjusted for baseline fasting and 2 h glucose. Results An increase in AHEI score was associated with weight loss in ILS [β per 10-point increase (SE) -1.2 kg (0.3, p < 0.001)], metformin [− 0. 90 kg (0.2, p < 0.001)] and placebo [− 0.55 kg (0.2, p = 0.01)]. However, AHEI change was not associated with incident diabetes in any group before or after adjustment for weight change. Conclusions Controlling for weight, diet quality was not associated with diabetes incidence but helps achieve weight loss, an important factor in diabetes prevention.


Circulation ◽  
2017 ◽  
Vol 136 (1) ◽  
pp. 52-64 ◽  
Author(s):  
Ronald B. Goldberg ◽  
Vanita R. Aroda ◽  
David A. Bluemke ◽  
Elizabeth Barrett-Connor ◽  
Matthew Budoff ◽  
...  

Diabetes ◽  
2019 ◽  
Vol 68 (12) ◽  
pp. 2337-2349 ◽  
Author(s):  
Zsu-Zsu Chen ◽  
Jinxi Liu ◽  
Jordan Morningstar ◽  
Brandy M. Heckman-Stoddard ◽  
Christine G. Lee ◽  
...  

Author(s):  
Ronald B Goldberg ◽  
Mark T Tripputi ◽  
Edward J Boyko ◽  
Matthew Budoff ◽  
Jeanne M Clark ◽  
...  

Abstract Purpose To characterize hepatic fat content and fatty liver prevalence, their determinants, and effect of interventions to prevent diabetes using computerized tomography in a cohort with prediabetes, in those developing diabetes versus not. Methods We measured liver fat as liver attenuation (LA) in Hounsfield units in 1876 participants at ~14 years following randomization into the Diabetes Prevention Program, which tested the effects of lifestyle or metformin interventions versus standard care to prevent diabetes. LA was compared among intervention groups and in those with versus without diabetes, and associations with baseline and follow-up measurements of anthropometric and metabolic covariates were assessed. Results There were no differences in liver fat between treatment groups at 14 years of follow-up. Participants with diabetes had lower LA (mean ± SD: 46±16 vs. 51±14HU; p&lt;0.001) and a greater prevalence of fatty liver (LA&lt;40HU) (34% vs 17%; p&lt;0.001). Severity of metabolic abnormalities at the time of LA evaluation were associated with lower LA categories in a graded manner and more strongly in those with diabetes. Averaged annual fasting insulin (an index of insulin resistance [OR, 95% CI 1.76, 1.41-2.20]) waist circumference (1.63, 1.17-2.26), and triglyceride (1.42, 1.13-1.78), but not glucose, were independently associated with LA&lt;40HU prevalence. Conclusions Fatty liver is common in the early phases of diabetes development. The association of LA with insulin resistance, waist circumference and triglyceride levels emphasizes the importance of these markers for hepatic steatosis in this population and that assessment of hepatic fat in early diabetes development is warranted.


2008 ◽  
Vol 27 (1, Suppl) ◽  
pp. S91-S98 ◽  
Author(s):  
Sherry L. Pagoto ◽  
Lyle Kantor ◽  
Jamie S. Bodenlos ◽  
Mitchell Gitkind ◽  
Yunsheng Ma

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 45-LB
Author(s):  
VINAY CHIGULURI ◽  
DOUGLAS BARTHOLD ◽  
RAJIV GUMPINA ◽  
CYNTHIA CASTRO SWEET ◽  
JASON PIERATT ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document